We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Igraine plc | AQSE:KING | Aquis Stock Exchange | Ordinary Share | GB00BM9CKV18 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.30 | 0.10 | 0.35 | 0.30 | 0.225 | 0.30 | 0.00 | 16:29:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/1/2024 13:30 | Current share price 19th. January 2024: 0.3p 83,023,385 shares in issue Market capitalisation: £249,070. "Empowering Excellence At the heart of investment in life sciences and breakthrough technologies Igraine PLC specialises in investing in breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors." "The Company's investment strategy is focused on businesses and companies in the service and technology sectors, including products related to social or life enhancement. The Directors intend to identify investee businesses and companies where they perceive the opportunity for significant growth through early stage opportunities and/or market opportunities. It is intended that the Company will, principally, invest through secured convertible loan notes or acquire controlling shareholdings in UK based or overseas companies whose managements are proposing to seek a stock market quotation in the short/medium term, although the acquisition of minority interests in companies already admitted to the AIM market of the London Stock Exchange or AQSE Growth Market will not necessarily be precluded. The Directors will also consider investment opportunities where the natural exit strategy will be through a trade sale." Notice of GM, Board Changes and Change of Adviser 11 June 2021, 14:39 Source - LSE Regulatory RNS Number : 6865B Angelfish Investments PLC 11 June 2021 "Notice of GM, Board Changes and Co-Investment Agreement with Excalibur Healthcare Services under New Investment Strategy Change of Corporate Adviser to Peterhouse Capital Limited General Meeting The Company announces that it has today posted a circular and Notice of General Meeting ("General Meeting") to shareholders of the Company ("Circular") to be held at the offices of Peterhouse Capital Limited at 3rd Floor, 80 Cheapside, London, EC2V 6EE, at 10.30 a.m. on 28 June 2021 at which the Resolutions will be proposed to, inter alia, approve the Proposed Directors, to give the Directors authority to issue the New Ordinary Shares, to amend the Investment Strategy and to change the name of the Company to Igraine PLC. A copy of the Circular and Notice of General Meeting can be found at the Company's website: hxxp://www.angelfish Proposed Fundraising Peterhouse Capital Limited has placed 77,519,230 new Ordinary Shares at a post-consolidated subscription price of £0.025807, raising £2,000,500 before expenses ("the Subscription"). Of the £2,000,500, £1,900,500 (73,644,237 ordinary shares) is conditional upon the approval of the Proposals at the General Meeting and lifting of the current Ordinary Share suspension, and £100,000 will be raised immediately through the immediate issue of 3,874,992,734 ordinary shares. The existing Director's participation in the Subscription and Options is conditional on the publication of the Company's audited financial results to 31 December 2020 via a Regulatory Information Service provider. Change of Corporate Adviser The Company is pleased to announce that Peterhouse Capital Limited has been appointed as the Company's AQSE Growth Market Corporate Adviser & Corporate Broker with immediate effect. Proposed Board Changes Subject to the General Meeting Resolutions passing the following Board changes will take place immediately. Sir Professor Christopher Evans (aged 63) - Executive Chairman Professor Sir Christopher Evans is the founder and Chairman of Excalibur Group and a renowned scientist and highly successful entrepreneur with numerous prestigious awards and medals for his work over the last 30 years during which time he has built more than 50 medical companies from start-up and floated 20 new medical businesses on stock markets in six different countries. He has created 11 successful academic spin-outs and companies worth over $2.4 billion, and has raised $2.6 billion from disposals. He directed the raising of approximately $450 million for Merlin Biosciences Funds and $2.6 billion from disposals including the sale of BioVex Group, Inc. to Amgen Inc. and Piramed Limited to Roche Group. Through Merlin Ventures Limited, he co-founded and advised Biotech Growth Trust plc. Arakis Limited, one of the companies developed by Chris Evans was sold to Sosei Co. Ltd for $187 million. Chris Evans has founded notable companies such as Chiroscience, Celsis, ReNeuron, Vectura, Biovex and Merlin Biosciences Ltd. Appointed an OBE in 1995 for services to medical bioscience he was knighted in 2001 for services to bioscience and enterprise. Latterly he was founder of Arix Bioscience plc (LSE:ARX), of the oncology specialist Ellipses Pharma Limited and of Excalibur Healthcare Services Ltd. Stephen "Steve" David Winfield (aged 28) - Executive Director Stephen Winfield is currently the commercial director and a board director of Excalibur Healthcare Services Ltd. He has a track record of building, financing and selling various businesses from the ground up. His experience spans 9 years in building and managing teams across the technology, food and beverage and healthcare sectors, primarily alongside Professor Sir Christopher Evans OBE. He has managed over £170m of transactions acting as a director of various companies and helped raise in excess of £20m to date for private businesses in the UK. More recently Stephen has been advising Scoffs Group (UK's largest Costa Coffee franchisee). Martin Walton (aged 57) - Executive Director Martin Walton is currently Chairman and CEO, Bradshaw Consulting Ltd, a Strategic Advisory group assisting companies and shareholders in creating, generating and realising value from investments in life sciences and tech sectors. In 2020 he set up and now manages Excalibur Medicines Ltd to develop the AZD1656. He is a director of Interrad Medical, a Minneapolis-based medtech company. Previously he was Vice Chairman of Simbec-Orion Group a specialist CRO which he sold to private equity for a 3x return. He has been Executive Chairman of Iota Sciences Ltd, a spin-out from Oxford University with revolutionary technology in microfluidics. With Professor Sir Chris Evans he assisted in founding Arix Bioscience in 2016 and listed it on the LSE in 2017. He was co-founder and CEO of Arthurian Life Sciences Ltd, the manager of the top-decile Wales Life Sciences Investment Fund, an innovative hybrid of private and public equity. He was CEO of Excalibur Group 2010 - 2016, and CEO of both Excalibur Fund Managers (Life Sciences VC / PE fund manager) and Excalibur Healthcare Services (provision of healthcare services and facilities). Prior to this he had a highly successful 25 year career in investment banking and investment management. ..." Angelfish Inv. PLC - RESULT OF GENERAL MEETING AND PROPOSALS 29th June 2021, 07:00 RNS Number : 3917D Angelfish Investments PLC 29 June 2021 "The Company is pleased to announce that at the General Meeting of Shareholders held yesterday, all resolutions were duly passed. The Company's name will change to 1graine plc and the change of name will be effective once Companies House has issued a certificate of change of name (the "Certificate"). A further announcement confirming the change of name and new Company website will be made in due course. Upon issue of the Certificate, the Company's ordinary shares, shall be traded on AQSE Growth Market under the ticker "KING". The new ISIN number will be GB00BM9CKV18 and the SEDOL will be BM9CKV1. The Co-Investment Rights The Co-Investment Rights agreement with Excalibur Healthcare will become effective immediately. The Company has been granted the rights to co-invest in all healthcare and life-science investment opportunities sourced or invested into by Excalibur Healthcare Services. Fundraising With the Resolutions having been approved, the fundraising of £1,900,500 (73,644,237 ordinary shares) will now be processed. The unconditional fundraise of £100,000 (3,874,992,734), Ordinary Shares will also now be allotted on a post-consolidation basis so that 3,874,993 Ordinary Shares will now be issued. The existing Director's participation in the Subscription and Options is conditional on the publication of the Company's audited financial results to 31 December 2020 via a Regulatory Information Service provider. Board Changes The following new Directors will join the Board immediately: Sir Professor Christopher Evans (aged 63) - Executive Chairman Stephen "Steve" David Winfield (aged 28) - Executive Director Martin Walton (aged 57) - Executive Director Admission & Total Voting Rights Following the issue of the 3,874,992,734 new Ordinary Shares (3,874,993 new ordinary shares on a post-consolidated basis) and the 73,644,237 Subscription Shares, the Company's issued ordinary share capital shall consist of 83,023,385 ordinary shares of 0.002 pence each. ..." 03 Aug 21, 07:00 Igraine PLC - Change of Name to Igraine plc "IGRAINE PLC (Previously: Angelfish Investments plc) ("Company" or "Igraine"") Change of Name to Igraine plc The Company is pleased to announce that Companies House has issued a change of name certificate on 28 July 2021 to the Company, and the name change to Igraine plc has become effective immediately. The new ticker symbol is "KING" with immediate effect. The Company's website is www.Igraineplc.com ..." | hedgehog 100 | |
13/6/2008 20:54 | The Covenant People | goinbroke | |
13/6/2008 20:40 | As If a 10 (Lost "Literally") Tribe of Northern Israel can Compete Bar Napthali! Bri'Tish Great Bri'Tain | goinbroke | |
13/6/2008 20:20 | No Message! | goinbroke | |
11/1/2008 15:06 | The BOE is so stoopid it cant see what the rest of us have seen for a couple of months, which is an economy that is faltering quite significantly. | imprima2 | |
10/1/2008 08:34 | we are here | moob | |
07/1/2008 23:38 | roll on thurs | moob | |
06/1/2008 10:35 | The problems is that they need to cut rates because falling house prices are scuppering the Northern Rock Deal. The taxpayer has already provided guarantees worth £57bn so the govt need this problem off their plate. Half a point reduction this week on Thursday, imho. This govt is a shambles, just look at the recent increase in corporation tax for small companies - thats going to stop investment from many altoghether. Kick out King, Darling and Brown. | moob | |
05/1/2008 14:45 | If they cut rates again i hope they will officially change there remit becuase it should be that their main aim is to control inflation which they are not doing. Real! inflation is running over 10% If their remit has changed to supporting housing market at all costs with lower rates then they should state that and we all know where we stand then. | divinausa1 | |
05/1/2008 14:40 | The pressure is mounting on the Bank to provide some relief at next week's monetary policy meeting. | moob | |
29/12/2007 20:47 | rates at 4% by end 08 my prediction. or sooner. | moob | |
02/12/2007 09:18 | KING HELL: Mervyn King faces one of his toughest decisions yet. Will he or wont he cut rates this week?? | moob | |
10/9/2005 17:07 | HERE WE HAVE A SELF MADE MULTI MILLIONAIRE WHO IS PUTTING HIS MONEY INTO EXPOSING THE CORRUPTION AND LIES OF THE USA PRO ZIONIST NEW PROJECT CENTURY ADMINISTRATION...HE HAS BEEN ISSUED WITH DEATH THREATS BUT THIS GUY DOESN'T CARE A TOSS ABOUT THIS VERMIN...A TRUE AMERICAN HERO...PLEASE SUPPORT HIS CAUSE AT GET HIS TRUTH DVD SUPERFAST AT WWW.QXL.COM OR WWW.EBAY.CO.UK JUST PUT IN 9/11 DVD IN SEARCH VOTE JIMMY WALTER FOR PRESIDENT...TIME AMERICA WAS GIVEN BACK TO THE GOOD PATRIOTS! | maestro. | |
11/3/2005 07:18 | Analise the lunatics heading Why I am Short Jacob Rothschild, Elizabeth II and Long Charles III and William V I beleive the idiot has missed out the punctuation. it should read Why I am Short. Jacob Rothschild, Elizabeth II and Long Charles III and William V The fool now thinks hes related to money, royalty a pirate and the dutch! And blames them. Well Mr James you can forget William V because the Dutch are the tallest people around. I would suggest the reason youre short is due to the weight of the world you carry on your shoulders. GO GET SOME THERAPY!! | pomp circumstance | |
11/3/2005 07:00 | DRAX, wakee wakee! | theberg | |
10/11/2003 11:52 | or even : www.throneout.com !! | sugarbeast | |
10/11/2003 11:29 | thoneout.com | b1gchipper | |
08/11/2003 00:19 | there were four in the bed and the little one said roll over, roll over... | sniffer333 | |
07/11/2003 23:42 | For someone it is the posthumous curse hurled from the dead wife, Diana, directly from up there. And perhaps it begins to believe itself it it also he, the prince Carlo, admirable when pretends to interest itself to the beauties of the sultanate of the oman, where it is found in official visit. While to London the scandal is exploded more devastating of these last twelve years of scandals of the real family. Carlo to read with a man, with its valletto housekeeper. It is such gross that newspapers and English televisions received the order of the court of not to tell the facts. Up to now they have alone been able to say that in the event a person of the real family it is involved. Without to do the name of Carlo. But since the news move about the same -across internet and the foreign televisions- Carlo has seen compelled to deny and with that reveals that the person of the real family in matter is actual he. Its personal secretary declared: "are accusations defaming, entirely fake and ridiculous". The printing satirizes: Carlo says that whatever is, he did not do it. But how it this is born story? It is an I continue some venoms between Carlo and Diana. The princess, little before to die, would have left a tape carved with its voice. In which it tells that a waiter of their palace -such George Smith- revealed to to be been raped them two times from another employee of the palace. Not only. But it told to have found them, a morning while carried the breakfast in room, the same one stupratore to read with a component of the real family. The stupratore has been Michael Fawcett, former secretary housekeeper of Carlo, from beyond vent' years to its service. If it is true, Diana blundered a thing: when said, reporting itself to the amante of Carlo, Camilla Parker Bowles: "in my marriage we are in three". It should have said: we are in four. | enochthenocker | |
07/11/2003 23:37 | Yup sounds about right! | porksword |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions